The proto-oncoprotein Bcl-3 is a member of the IkB family and is present predominantly in the nucleus. To gain insight into speci®c nuclear functions of Bcl-3 we have isolated proteins that interact with its ankyrin repeat domain. Using the yeast two-hybrid-system we identi®ed four novel binding partners of Bcl-3 in addition to NF-kB p50 and p52, previously known to associate with Bcl-3. The novel Bcl-3 interactors Jab1, Pirin, Tip60 and Bard1 are nuclear proteins which also bind to other transcription factors including c-Jun, nuclear factor I (NFI), HIV-1 Tat or the tumor suppressor and Polll holoenzyme component Brca1, respectively. Bcl-3, p50, and either Bard1, Tip60 or Pirin are sequestered into quarternary complexes on NF-kB DNA binding sites, whereas Jab1 enhances p50-Bcl-3-DNA complex formation. Furthermore, the histone acetylase Tip60 enhances Bcl-3-p50 activated transcription through an NF-kB binding site, indicating that quarternary complexes containing Bcl-3 interactors modulate NF-kB driven gene expression. These data implicate Bcl-3 as an adaptor between NF-kB p50/p52 and other transcription regulators and suggest that its gene activation function may at least in part be due to recruitment of the Tip60 histone actetylase.
Introduction
Bcl-3 was originally identi®ed as a putative protooncogene which was frequently rearranged in chronic B cell lymphocytic leukemia (Ohno et al., 1990) . Bcl-3 is a member of the IkB multigene family which modulates the activities of NF-kB/Rel transcription factors (Baeuerle and Baltimore, 1996; Baldwin, 1996; Siebenlist, 1997; Wulczyn et al., 1996) . The mammalian NF-kB/Rel family consists of ®ve proteins to date: p50, p52, RelA (p65), c-Rel and RelB; p50 and p52 are generated by processing from their precursors, p105 and p100, respectively. Dimers of NF-kB/Rel factors are sequestered into the cytoplasm by the IkB proteins IkBa, IkBb and IkBe. In addition, the precursor proteins p100 and p105 have IkB properties and can withdraw NF-kB/Rel factors into cytoplasmic complexes (Wulczyn et al., 1996) . A common feature of all IkB family members, including Bcl-3, is a domain of six to seven ankyrin repeats which serves as a protein interaction surface and binds to the conserved Relhomology domain of NF-kB/Rel dimers. Although ankyrin repeats are found in a variety of proteins with diverse functions (Bork, 1993) , ankyrin repeats of the family of IkB proteins are more related to each other than to other ankyrin repeat proteins. Nevertheless, in vitro studies have demonstrated that the vertebrate IkB family members display dierent speci®cities towards distinct NF-kB/Rel proteins. Three groups of IkB ankyrin speci®cities can be distinguished; the precursor proteins p100 and p105 bind to all know mammalian NF-kB/Rel factors. IkBa, IkBb and IkBe strongly prefer dimers containing RelA or c-Rel. In contrast, Bcl-3 has a strong preference towards p50 or p52 homodimers (Franzoso et al., 1992; Hatada et al., 1992; Kerr et al., 1992; Nolan et al., 1993; .
A number of signaling pathways converge into NFkB activation by inducing degradation of the cytoplasmic IkB proteins, IkBa, IkBb or IkBe (May and Ghosh, 1997) . IkB-speci®c kinases IKKa and IKKb have been identi®ed that respond to extracellular signals and phosphorylate IkBa or IkBb (Maniatis, 1997; Stancovski and Baltimore, 1997) . As a result, induced IkB degradation as well as p50 or p52 processing from their precursors is executed by the proteasome following ubiquitination (May and Ghosh, 1997) . In contrast, no such posttranslational modifications have been described for Bcl-3, the only IkB-like protein that is not degraded after signaling and that is primarily localized in the nucleus.
The cellular function of Bcl-3 remains largely obscure. Various studies have suggested that Bcl-3 acts to increase transcription from NF-kB responsive promoters. On the one hand, Bcl-3 can, like other IkBs, dissociate its preferred NF-kB/Rel factors (p50 and p52 homodimers) from DNA. Thus, Bcl-3 may antagonize p50 mediated inhibition of NF-kB target genes by sequestering p50 homodimers, which lack transactivation domains. As a consequence, Bcl-3 may increase access of activating NF-kB RelA-p50 to the cis regulatory sites (Franzoso et al., 1992) . On the other hand, Bcl-3 may form activating complexes with p50 or p52 dimers on DNA (Bours et al., 1993; Fujita et al., 1993) by providing transactivation domains on both sides of the ankyrin repeat domain (Bours et al., 1993) .
The situation is further complicated by the ®nding that Bcl-3 is phosphorylated and that its phosphorylation status aects the interaction with both p50 and p52 . In addition, Bcl-3 may form both heterotrimeric and heterotetrameric complexes with p50 or p52 homodimers (Bundy and McKeithan, 1997; Wulczyn et al., 1992) . Consequently, Bcl-3 can have dierent eects on p52 or p50 binding to DNA, depending on its phosphorylation and/or concentration (Bundy and McKeithan, 1997) . For example, it can enhance p50 (Caamano et al., 1996) or p52 (Bundy and McKeithan, 1997) homodimer binding to DNA, without being a stable component of the complex. Furthermore, constitutive expression of Bcl-3 enhances the amount of p50 homodimers in the nucleus, apparently by liberation of p50 from cytosolic p105-p50 complexes (Watanabe et al., 1997) .
Physiological functions of Bcl-3 have been revealed by the generation of Bcl-3 de®cient mice (Franzoso et al., 1997; Schwarz et al., 1997) . Bcl-3 is required for T cell dependent immunity. Bcl-3 de®cient mice are defective in antigen speci®c antibody production, germinal center formation and are unable to cope with L. monocytogenes or T. gondii infection (Franzoso et al., 1997; Schwarz et al., 1997) .
Since little is known about speci®c molecular Bcl-3 functions and its integration into gene regulatory pathways, we set out to identify additional Bcl-3 interacting proteins. Using a yeast interaction trap assay we identi®ed four nuclear co-factors which interact with the ankyrin repeat domain of Bcl-3. We have analysed the eect of these Bcl-3 interacting proteins on supercomplex formation with Bcl-3 and p50 bound to an NF-kB DNA binding site, on the activity of cellular p50-Bcl-3 complexes and on coactivation of Bcl-3 stimulated transcription. Our data suggest that Bcl-3 connects distinct NF-kB/Rel complexes to a network of other gene regulators and chromatin remodeling co-factors.
Results

Bcl-3 interacts with several nuclear co-factors
In an attempt to identify nuclear downstream targets of Bcl-3 we employed the yeast-two-hybrid system (Fields and Song, 1989) to screen for Bcl-3 interacting proteins in an expression cDNA library derived from human activated B cells fused to the Gal4 transactivation domain. Since both full length (amino acids 1 ± 446) and carboxy-terminally truncated Bcl-3 (amino acids 1 ± 360) linked to the Gal4-DNA-binding domain were transcriptionally active in yeast, probably due to the transactivation domains of Bcl-3 (Bours et al., 1993) , we used the ankyrin repeat domain (repeats 1 ± 7, amino acids 124 ± 360) for screening. A total of approximately 1610 7 independent clones were analysed and several speci®cally interacting cDNA clones were identi®ed. Two of them encoded for p50 and p52, both known to interact with the Bcl-3 repeat domain (Franzoso et al., 1992; Nolan et al., 1993; . Novel Bcl-3 interacting proteins were Pirin, Tip60, Jab1, and Bard1 (Table 1) . These proteins had previously been shown to interact with nuclear factor I/ CCAAT box transcription factor (NFI/CTF1) (Wendler et al., 1997), HIV-1 Tat (Kamine et al., 1996 ), c-Jun (Claret et al., 1996 and Brca1 (Wu et al., 1996) , respectively.
Quantitative b-Galactosidase assays showed that Bcl-3 interacted with Pirin with similar strength than with p50 whereas Bard1, Jab1 or Tip60 were bound somewhat weaker in this assay. The candidate clones failed to interact with the Gal4-DNA-binding domain, with a Gal4-LaminC hybrid or a Gal4-C/EBPb hybrid used as controls (data not shown). Similar results were obtained in the yeast strain GC1945 and histidine auxotrophy selection (data not shown).
Next, we examined the speci®city of the candidate clones for lkB ankyrin repeat domains, using human Bcl-3, lkBa and lkBb, respectively (Table 1 ). Tip60 and Pirin had a clear preference for Bcl-3. In contrast, Bard1 interacted with lkBa more strongly than with Bcl-3.
Various deletion mutants of Bcl-3 were then employed to determine the structural requirements for the interactions (Table 2) . Similar to what has been shown in vitro for p50-Bcl-3 complex formation , the interaction of Pirin or Tip60 with Bcl-3 required all seven repeats of Bcl-3. In contrast, Jab1 or Bard1 activated b-Gal expression when co-transfected with a Bcl-3-deletion mutant containing only ®ve ankyrin repeats. Deletion mutants containing less than four ankyrin repeats were unable to interact with any of the clones (Table 2 and data not shown).
Next, GST-pulldown assays and co-immunoprecipitation analysis were used to examine Bcl-3 interactions ( Figure 1a ). All candidate polypeptides bound to GST- Various ankyrin repeat domains were cloned into pGBT9 plasmids and used as baits, as indicated. Encoded amino acids are shown in parenthesis. b-galactosidase activity was activity was determined in liquid assays Bcl-3 deletion mutants in pGBT9 compared to the full length repeat domain (Table 1) . Encoded amino acids (in parenthesis) and number of ankyrin repeats (AR) are indicated. The interacting proteins were in pACT. b-galactosidase activity was determined in liquid assays
Nuclear co-factors for Bcl-3
Bcl-3ARD, whereas binding to GST was negligible. Speci®c Bcl-3 interactions were con®rmed in each case by reciprocal co-immune precipitations with antisera against Bcl-3 or against the tagged interacting proteins as shown in Figure 1b . When co-translated, an antiBcl-3 antibody co-precipitated Bcl-3 and each of the interacting proteins (lane 5). Similarly, an anti-Flag antibody co-precipitated Flag-tagged Bcl-3 interacting proteins together with Bcl-3 (lane 6). The precipitations were speci®c, since neither the anti-Bcl-3 antibody reacted with the interacting proteins (lane 4), nor the anti-Flag antibody precipitated Bcl-3 (not shown). To examine whether interactions occured in vertebrate cells we transfected human 293 cells with Bcl-3 and interacting protein expression vectors as shown in Figure 1c . It is evident that all four proteins tested, p50, Tip60, Pirin, and Jab1, respectively, co-immunoprecipitated with Bcl-3 indicating that high anity interactions with Bcl-3 occurred in intact cells. Taken together these results show that the identi®ed proteins form stable complexes with Bcl-3.
Supercomplex formation and modulation of p50-Bcl-3 DNA-binding activity by Bcl-3 interacting proteins
Bcl-3 can associate with p50 and depending on the conditions the Bcl-3 complex dissociates from DNA or stays bound, resulting in the formation of a ternary complex (Wulczyn et al., 1996) . To examine the consequences of the novel Bcl-3 interactions on p50/ Bcl-3 complexes we choose experimental conditions where p50 and Bcl-3 are bound to each other and to DNA ( Figure 2 ). Addition of reticulocyte lysate, GST, Tip60, Bard1, Pirin or Jab1 in the absence of Bcl-3 did Human 293 cells were transfected with expression vectors encoding amino terminally tagged versions of the indicated proteins (T7-tagged Bcl-3 and Flag-tagged interacting proteins, p50, Tip60, Pirin, Jab1, respectively). Cells were lysed and 10% of the lysate served as expression control (EC) in Western blots using anti-Flag antibody (lanes 1 ± 3, 9, 10 and 13). Mocktransfected cells are shown in lane 4. Bcl-3 was immunoprecipitated using anti-T7 antibody (IP). Co-precipitated proteins were revealed by immunoblotting using anti-Flag antibody (lanes 5, 6, 11 and 12) . No co-precipitation was observed in the absence of Bcl-3 or in mock-transfected cells (lanes 7 and 8). The Flagtagged ankyrin repeat domain of Notch1 served as a negative control and was not precipitated with Bcl-3 (lane 14)
Figure 2 Bcl-3 interacting proteins enhance the DNA binding activity of p50-Bcl-3 and form quarternary complexes with p50, Bcl-3 and an NF-kB DNA binding site in vitro. Gel retardation assay was performed with reticulocyte lysate alone (lane 1), p50 (lanes 2 ± 8) or p50 and Bcl-3 (lanes 9 ± 14). p50-DNA binding activity was unaltered in the presence of reticulocyte lysate (lane 3), GST (lane 4), Tip60 (lane 5), Bard1 (lane 6), Pirin (lane 7) or Jab1 (lane 8). The p50-Bcl-3 complex bound to DNA (lane 9) was not changed by the addition of GST (lane 10), but was supershifted to a quarternary complex by addition of Tip60 (lane 11), Bard1 (lane 12) or Pirin (lane 13). Addition of Jab1 increased the DNA-binding activity of p50-Bcl-3 (lane 14), but did not result in a supershift. The Bcl-3 and p50 proteins used in this experiment were expressed in bacteria and puri®ed, however, similar results were obtained when p50 and Bcl-3 were generated by in vitro translation (data not shown) not alter the electrophoretic mobility of the p50-DNA complex (lanes 2 ± 8). Thus, the Bcl-3 interacting proteins did not interact with p50 directly. However, in the presence of Bcl-3, when a ternary p50-Bcl-3-DNA complex was formed (lanes 9 and 10), addition of Tip60, Bard1 or Pirin resulted in the formation of quarternary complexes with further retarded migration (lanes 11 ± 13). It is also evident that Pirin strongly increased the amount of the DNA-bound complex. Addition of Jab1 did not result in the formation of a quarternary complex, however the DNA binding activity of the ternary complex was signi®cantly increased. These data show that the Bcl-3 interacting proteins identi®ed modulate p50-Bcl-3 DNA-binding activity in dierent ways: Tip60 or Bard1 form quarternary complexes, Jab1 increases the DNAbinding activity of Bcl-3-p50 and Pirin has both eects.
Next, we investigated eects of the Bcl-3 interacting proteins on p50-Bcl-3 complex formation in vivo. HeLa cells, which stably express Bcl-3, were transfected with the Bcl-3 interacting clones. Bcl-3-associated NF-kB/ Rel activities were immunoprecipitated with an antibody directed against the C-terminus of Bcl-3. Subsequently, the precipitated complexes were detergent-dissociated and tested for release of NF-kB/Rel DNA binding activity by mobility shift analysis ( Figure  3 ). Almost no p50 homodimer activity was detected in mock-transfected or Bard1-transfected cells under these conditions. In contrast, expression of the other Bcl-3 interacting proteins led to a pronounced increase in Bcl-3-associated p50 dimers. The strongest increase in p50 DNA-binding activity was achieved by Jab1, followed by Pirin and Tip60. Thus, expression of Jab1, Tip60 or Pirin enhance association of Bcl-3 with p50 dimers, suggesting a functional interaction.
Tip60 enhances Bcl-3-p50 mediated transcriptional activation through an NF-kB binding site
The fact that Bcl-3 interacting proteins are either engaged in supercomplex formation or enhance DNA binding activity of p50-Bcl-3 complexes suggests that these factors should aect transactivation. To test for co-stimulatory eects of Bcl-3 interactors, we expressed Tip60, Bard1 or Jab1 together with p50 and Bcl-3 in Drosophila SL2 cells and assayed activation of a Pselectin promoter-luciferase reporter. A cis-regulating NF-kB site in this promoter is preferentially bound by p50 or p52 and can be activated by p50-Bcl-3 in BAEC or SL2 cells (Hirano et al., 1998; Pan and McEver, 1995) . Under conditions where Bcl-3 and p50 alone only weakly stimulated P-selectin transcription, addition of Tip60 led to a superactivation in a dosedependent fashion (Figure 4) . The P-selectin promoter was activated in the presence of p50 at the highest concentration of Bcl-3 approximately threefold (left bars). Addition of Tip60 led to an additional 3 ± 4-fold activation which entirely depended on Bcl-3. In the absence of Bcl-3 only a slight increase in reporter expression was observed even at the highest Tip60 concentration. Activation of the P-selectin promoter by p50/Bcl-3 and Tip60 depended on the intact NF-kB binding site (Hirano et al., 1998 , and data not shown). In contrast to Tip60, Jab1 did not superactivate transcription in the presence of Bcl-3 and p50 ( Figure  4 ) although enhanced reporter expression was seen at high Bcl-3 concentrations. Bard1 did not consistently co-stimulate under these conditions (data not shown). It is possible that Jab1 or Bard1 do not support activation in the P-selectin promoter context or that other adaptor proteins required by these factors are absent in Drosophila SL2 cells. Nevertheless, our data show that Tip60 modi®es gene expression via Bcl-3 through an NF-kB DNA binding site.
Discussion
Bcl-3 is a unique member of the IkB family of NF-kB/ Rel regulators as it is primarily localized in the nucleus and, unlike other IkB molecules, it is not proteolytically degraded after cellular stimulation with NF-kB activating agents. Among the NF-kB/Rel factors p50 or p52 are speci®cally bound by Bcl-3. Bcl-3 can either form stable complexes with these transcriptionally inactive homodimers on NF-kB DNA binding sites to activate transcription or dissociate them from DNA. To identify additional targets of Bcl-3 that may help to explain its downstream functions in gene regulation, we have screened for Bcl-3 interacting proteins in a B cell library using a yeast two hybrid system. p50 and p52 are among the isolated clones, demonstrating the eectiveness and speci®city of the screening procedure. All other clones encoded nuclear proteins which Figure 3 Ectopic expression of Bcl-3 interacting proteins increases the amount of endogenous p50-Bcl-3 complexes. Whole cell extracts were prepared from HeLa cells, which stably express Bcl-3 and which were transfected with the Bcl-3 interacting proteins. The extracts were used for immunoprecipitation with anti-Bcl-3 antiserum. The precipitates were washed, the complexes dissociated with detergent and the supernatant assayed for p50 DNA binding activity in a gel retardation assay Nuclear co-factors for Bcl-3had previously been identi®ed as co-factors of other transcription factors. These results suggest that Bcl-3 coordinates cross-talk between NF-kB/Rel transcription factors and a variety of other transcription regulators.
Various nuclear co-factors interact with Bcl-3
The novel Bcl-3 binding proteins identi®ed are summarized in Figure 5 . They included Tat-interacting protein Tip60; Pirin, a potential co-factor of nuclear factor I; Bard1, known to functionally interact with the tumor suppressor Brca1 and Jab1, which interacts with the transactivation domain of c-Jun (Claret et al., 1996; Kamine et al., 1996; Wendler et al., 1997; Wu et al., 1996) . The only common properties of the identi®ed factors is that they are nuclear proteins and associate with gene regulators. However, no shared sequence motifs in these proteins required for the interaction with Bcl-3 or with other transcription factors have yet been identi®ed. Furthermore, the factors belong to dierent protein families and little is known about the mechanisms each use to regulate transcription.
We have shown that Tip60 co-stimulates Bcl-3 activated transcription through an NF-kB binding site. Tip60 displays histone acetylase activity (Yamamoto and Horikoshi, 1997) , contains an atypical zinc ®nger motif and a putative acetyl CoA binding site and was shown to enhance Tat-mediated transcriptional activation of HIV-1 (Kamine et al., 1996) . An Nterminal chromolike domain in Tip60 is not required for Bcl-3 binding, since this region was missing in the isolated clone. Tip60 is related to the human monocyte leukemia zinc ®nger protein Moz, which was identi®ed as a chromosomal translocation with CREB-binding protein (CBP) in acute myeloid leukemia (Borrow et al., 1996) . The highest homology between Tip60 and Moz spans a region comprising the single C2HC zinc ®nger and a subregion similar to histone actetyltransferases and other actetyltransferases (MYST domain) (Borrow et al., 1996) . This region is also conserved in Drosophila Mof, which is required for gene dosage compensation (Hil®ker et al., 1997) and in the yeast Figure 5 Bcl-3 interacting proteins (BIP) establish a network between NF-kB-p50/p52 and other transcription factor families. Bcl-3 binds to transcriptional co-factors or adaptor proteins which in turn interact with other regulators, containing (c-Jun, NFI) or not containing (Tat, Brca1) own DNA binding domains. By interacting with Bcl-3 Jab1 facilitates DNA binding of Bcl-3-p50 complexes, whereas Pirin, Bard1 or Tip60 sequester Bcl-3-p50 into quarternary complexes Figure 4 Enhancement of the P-selectin promoter activity by Bcl-3 interacting proteins. Drosophila SL2 cells were transfected with a human P-selectin-luciferase reporter gene and combinations of Bcl-3, p50, Jab1 and Tip60, as indicated. Total DNA amounts in the transfections were kept equal by addition of the corresponding amounts of empty expression vector. The relative luciferase activities indicated are mean values from three to four independent transfections, respectively Sas2 and Sas3 proteins, which are involved in HMR silencing in yeast (Reifsnyder et al., 1996) .
Pirin, which most eciently formed complexes with Bcl-3 and p50 bound to DNA, has originally been isolated as a nuclear factor I (NFI) associated protein (Wendler et al., 1997) . It is predominantly present in nuclear dot-like structures and is devoid of known motifs, except for distant similarities with prokaryotic and yeast proteins of yet unknown function.
Jab1 belongs to the Mov-34 protein family whose members are involved in diverse functions involving macromolecular assembly (Asano et al., 1997) . Jab1 has been originally identi®ed by its ability to bind to the c-Jun transactivation domain (Claret et al., 1996) . Jab1 co-stimulates c-Jun activated transcription in HeLa or F9 cells and works as a co-activator for the Jun equivalent Pap1 in yeast, although Jab1 lacks transactivation domains (Claret et al., 1996) . Jab1 interacts with c-Jun and JunD, but not with JunB or vJun. Similar to what we found with Bcl-3-p50 complexes, Jab1 stabilizes DNA binding of c-Jun to a TRE AP-1 site (Claret et al., 1996) .
Bard1 (Brca1 associated RING domain) binds to an N-terminal region of the tumor suppressor gene product Brca1. Missense mutations in Brca1 which segregate with breast cancer susceptibility alleviate the Bard1-Brca1 protein interaction (Wu et al., 1996) . Structurally conserved domains of Bard1 are a conserved RING ®nger structure resembling that of Traf2, three consecutive ankyrin repeats and a Cterminal BRCT domain, also conserved in Brca1 (Wu et al., 1996) . Bcl-3 does not bind to Brca1 and hence, it does not recognize the conserved conserved residues in the Bard1-BRCT domain (RD, unpublished observations). Interestingly, a carboxyterminal domain in Brca1, containing the BRCT domain, has transactivation potential (Chapman and Verma, 1996; Monteiro et al., 1996) . It has also been shown that Brca1 is a component of RNA Pol II holoenzyme and thus may serve as an adaptor protein between the holoenzyme and gene-speci®c activators (Scully et al., 1997a) . Brca1, Bard1 as well as Rad51, a protein involved in double strand DNA break repair and homologous recombination, co-localize in S phase nuclear foci, but not in G1, and upon DNA damage, accumulate at sites of damaged replicating DNA (Jin et al., 1997; Scully et al., 1997b) .
Integrator function of the IkB type ankyrin repeat domain of Bcl-3
Pirin, Tip60 and Bard1 eciently formed quaternary complexes whereas Jab1 enhanced DNA binding activity of Bcl-3-p50. Whether Jab1 can be part of higher order complexes under dierent experimental conditions remains to be determined. Supercomplex formation of Bcl-3 with p50 and either Tip60, Pirin, or Bard1 demonstrates that the Bcl-3 ARD can be bound simultaneously by at least two dierent proteins (Figure 2 ). This is an intriguing observation, as the ARD is a widely used protein ± protein interaction surface, present not only in IkB proteins, but also in the Notch/lin-12 family of surface receptors, the transcription factor GABPb, the p53 regulator p53BP2, as well as the Ink4 family of cdk inhibitors. It is therefore of considerable interest to determine if the ability of the Bcl-3 ARD to simultaneously recognize several partners is unique, or if it is a feature common to the repeat domains of these other proteins. Interestingly, the interaction analysis with Bcl-3 deletion mutants showed that both Pirin and Tip60 required the full ARD of Bcl-3 for binary interaction. Likewise, the p50-Bcl-3 interaction requires the entire repeat domain of Bcl-3 . We do not know, however, the exact stoichiometry and whether the complexes contain one or two Bcl-3-molecules. The very similar migrations of Pirin, Tip60 or Bard1 supercomplexes, however, suggest similar stoichiometries in all complexes. In contrast, Jab1 and to a lesser extent Bard1, readily interacted with Bcl-3 mutants containing only ®ve of the seven repeats and Jab1 did not form supercomplexes. We have not addressed whether a speci®c interaction-code' exists between the various proteins and speci®c ankyrin repeat domains. However, it is obvious that preferences for various lkB repeat sequences exist. For example, Pirin and Tip60 display clear preference for Bcl-3, while Bard1 interacted more strongly with lkBa. As has been observed for the selectivity of the Rel-lkB interaction, preferences do not entirely preclude interactions with less preferred lkBs. Our data may also indicate that the in vivo targets of Bard1 or Jab1 could include lkBa. The determination of the preferred cellular targets, however, will have to await further analysis.
Expression of some Bcl-3 interacting proteins caused an increase of Bcl-3-bound p50 homodimers (Figure 3 ). These observations suggest that Bcl-3 is part of diverse cellular multiprotein complexes and that the expression level of the Bcl-3 interactors would determine the fraction of Bcl-3 and p50 found in common complexes. This conclusion is supported by preliminary gradient fractionation experiments using cellular extracts where Bcl-3 was partially found in larger multiprotein complexes (VH and CS, unpublished observations) which may contain the identi®ed interactor proteins.
In summary, Bcl-3 appears to be used as co-factor by a number of transcription factor systems in addition to NF-kB-p50 or p52. The Bcl-3 ankyrin repeat domain may thus provide adaptor or bridging functions between p50/p52 and other transcription factor families.
Potential functions of Bcl-3/co-factor interactions
One of the functions of Bcl-3 supercomplexes including Tip60/Bcl-3/p50 might be TAR-independent activation of the HIV-LTR by Tat, requiring the NF-kB binding sites (Taylor et al., 1994) . As shown previously, p50 homodimers are capable of activating transcription of the HIV-LTR through the conserved Rel domain in a puri®ed transcription system and activation depended on a co-factor fraction (Kretzschmar et al., 1992) . This fraction may contain Bcl-3 and Bcl-3-interacting proteins.
Activation by Bcl-3 is mediated by N-and Cterminal serine and proline rich transactivation domains in Bcl-3 in transfected cells (Bours et al., 1993) and in vitro (MR Pelletier and CS, unpublished) . Transcriptional co-stimulation by Tip60 observed with p50-Bcl-3 (this study) or HIV-1 Tat (Kamine et al., 1996) in transfected cells could be a consequence of the Nuclear co-factors for histone acetylase activity of Tip60 (Yamamoto and Horikoshi, 1997) . Alternatively, Tip60 could contain separate transactivation domains or could activate transcription by stabilization of the p50-Bcl-3-promoter complex.
Likewise, Jab1 could provide a link between p50-Bcl-3 and AP-1 in NF-kB and AP-1 dependent synergistic gene activation. Additional work will therefore be required to elucidate functions and mechanisms of Bcl-3 in HIV-pathology and AP-1 signaling. The identi®cation of co-factors for Bcl-3 in this work should thus provide the basis for understanding the complexity of gene regulation by Bcl-3 and of its cross-talk with other transcription factors.
Materials and methods
Library screening using the yeast-two hybrid system cDNAs encoding full length Bcl-3, Bcl-3DC and Bcl-3ARD were subcloned into the BamHI site of the yeast expression vector pGBT9 (Clonetch). The vectors pLam and pC/EBPb, consisting of Gal4 (1 ± 147) and human lamin C (66 ± 230) or the leucine zipper of C/EBPb (243 ± 317), respectively, were used as controls. For library screening the yeast reporter strain Y190 (Trp-Leu-His-, LacZ7) was sequentially transformed with the plasmid pGBT9-bcl-3ARD and a human activated B-cell c-DNA library (Clontech) according to the manufacturer's protocol (Clontech, Palo Alto, CA, USA). Out of 1610 7 transformants, plated on selection medium, nine positive clones (His+, LacZ+) were found. The c-DNA library plasmids were recovered from yeast and reintroduced into the yeast reporter strain Y190 and HF7c to con®rm speci®city of the interaction. To determine bgalactosidase activity in yeast, three colonies of simultaneously transformed Y190 yeast cells were grown in 5 ml cultures overnight to an OD(600) of 1.0 ± 1.2. Cell extracts were prepared using standard conditions, and enzyme activity was determined using ortho-nitrophenyl-b-D-galactopyranoside (Sigma). Positive clones were sequenced using an automated LiCOR DNA sequencer. Data base comparisons were performed essentially with the BLAST programme (Altschul et al., 1997) . Full-length Tip60 was obtained by PCR from the B cell library described previously.
The sequences of synthetic oligonucleotide primers to construct lkBaARD (primer 1F and 1R), lkBbARD (primer 2F and 2R), Bcl-3ARD1-5 (primer 6F and 6aR), Bcl-3ARD1-4 (primer 6F and 6bR), or Bcl-3ARD1-3 (primer 6F and 6cR) by PCR were: 1F, GCGAATTCCCCGGGTG-GAAGCAGCAG; 1R, GCGGATCCTGGCAGCATCTGA-AGG; 2F, GCGAATTCCCCGGGCTCGTCTTCGGCTAC-G; 2R, GCGGATCCGGGCTCAGGGGCTCCGTG; 6F, GCGAATTCCCCGGGACCCGTGCAGATG; 6aR, GCG-GATCCTTGCGCGTTTACATGAGG; 6bR, GCGGATCC-GTCGATGTCGGCACCGCG and 6cR, GCGGATCC-CAGGTCCAACGTGCCCGG. PCR constructs were cloned into pGBT9.
GST-pulldown and immunoprecipitation of in vitro translated proteins
The cDNAs of the Bcl-3 interaction partners were subcloned into the XhoI site of the pCDNA1 expression vector, which has an upstream in frame start codon and a¯ag-epitope (MADYKDDDKS). Full length bcl-3 was inserted into the expression vector pCDNA3. Bcl-3ARD-GST was bacterially expressed as described For GSTpulldown assays pCDNA1-Flag plasmids containing candidate clones were in vitro transcribed and translated in the presence of [ 35 S]methionine in a nuclease-treated reticulocyte lysate (TNT 1 Promega). The radiolabeled polypetides were incubated with bacterially expressed and puri®ed GST or Bcl-3ARD-GST in the presence of glutathioneagarose beads. The binding assays were performed in modi®ed NETN buer containing 50 mM Tris pH 8.0, 100 mM NaCl, 1% NP40, 1 mM DTT, 20% glycerol. After 2 h incubation at 48C the glutathione-sepharose beads were washed ®ve times in modi®ed NETN buer. Beads were heated in Laemmli buer and supernatants analysed by SDS-gel electrophoresis.
For co-immunoprecipitation the pCDNA1-Flag-plasmids containing the isolated cDNA clones and the pCDNA3-bcl-3 plasmids were in vitro transcribed and translated in the presence of [ 35 S]methionine in 25 ml rabbit reticulocyte lysate. Immunoprecipitations were carried out by mixing 10 ml of reticulocyte lysate containing radiolabeled Bcl-3 and/or the interacting proteins, 20 ml staphylococcal protein A-sepharose beads (50% slurry, Promega) and the indicated antiserum (3 ml anti-Flag M2 antibody (Kodak), 3 ml anti-HA antibody (Boehringer) or 3 ml anti-Bcl-3 antibody (against the Nterminus of Bcl-3) in binding buer (50 mM Tris pH 8.0, 100 mM NaCl, 1% NP40, 1 mM DTT and protease inhibitors, Pefabloc, 0.4 mM aprotinin, 1 mg/ml, leupeptin, 1 mg/ml, pepstatin A, 1 mg/ml). Beads were washed in binding buer seven times, resuspended in Laemmli buer, heated and centrifuged. The supernatants were separated on a 12% SDS-polyacrylamid gel.
Immunoprecipitation from transfected 293 cells
Human kidney 293 cells were transfected with expression plasmids encoding T7 tagged Bcl-3 and pCDNA1 encoded Bcl-3 interacting, FLAG-tagged proteins as indicated in the ®gure legend. Cells were lysed in`whole cell' lysate buer, containing 20 mM HEPES (pH 7.9), 350 mM NaCl, 20% glycerol, 1 mM MgCl 2 0.5 mM EDTA, 0.1 mM EGTA, 1% NP-40 and protease inhibitors. Cell lysates were diluted 1 : 3 and proteins were immunoprecipitated using T7 tag-antibody (Novagene). Precipitates were washed with 50 mM Tris pH 8.0, 100 mM NaCl, 0.5% NP40, 1 mM DTT, subjected to SDS ± PAGE, blotted to PVDF membrane and probed with anti FLAG M2 antibody (Kodak). Antibody binding was revealed using ECL-detection (Amersham).
Gel shift experiments p50 (amino acids 1 ± 368) was expressed in the E. coli strain BL21(DE3)pLysS, using the expression plasmid pETp50 as described (Hatada et al., 1992) . Full length Bcl-3 or Tip60 were subcloned into the XhoI site of pGEX4T-2. The GSTfusion proteins were expressed and puri®ed from the Escherichia coli strain HB101 as described previously (Dhordain et al., 1997) . The Bcl-3-interacting proteins Jab1, Bard1 and Pirin were prepared by non-radioactive in vitro transcription/translation in rabbit reticulocyte lysate (TNT 1 , Promega). Ecient quarternary complex formation was observed with Tip60 prepared either in bacteria or by in vitro translation (not shown). The DNA probe contained the kB site from the MHC-enhancer (H2K) and was end-labeled with 32 P-dATP. Protein fractions and the DNA probe were incubated at 308C for 30 min in 20 ml binding buer containing 2 mg poly (dl-dC), 1 mg BSA, 1 mM DTT, 20 mM HEPES (pH 8.4), 60 mM KCl and 8% Ficoll. The DNA ± Protein complexes were analysed by electrophoresis on a 5% polyacrylamide native TBE gel.
Immunoprecipitation/gel shift analysis of cellular Bcl-3-p50 complexes HeLa clone Bf16, which stably expresses Flag-tagged Bcl-3, was transiently transfected with 6 mg of the Bcl-3-interaction partners by calcium-phosphate precipitation. Cells were harvested 36 h after transfection and lysed in 500 ml`whole cell' lysate buer, containing 20 mM HEPES (pH 7.9), 350 mM NaCl, 20% glycerol, 1 mM MgCl 2 0.5 mM EDTA, 0.1 mM EGTA, 1% NP-40 and protease inhibitors. The extract was diluted 3.25-fold with 20 mM HEPES and subjected to immunoprecipitation overnight with 3 ml antiBcl-3 antiserum (Santa Cruz, C-14) and Protein A Sepharose. Beads were washed several times with buer D (20 mM HEPES (pH 7.9), 100 mM KCl, 10% glycerol, 0.1 mM EDTA, 1 mM DTT, 1% NP-40, 0.5 mM PMSF) and once with buer D without NP-40. Immunoprecipitated material was eluted on ice in 20 ml buer D, containing 0.8% deoxycholate for 15 min, adjusted to 1.2% NP-40 and analysed by EMSA with the H2K probe.
Transient transfection of Drosophila Schneider cells
The expression constructs pPacp50 and pPacBcl-3 have been described previously (Hirano et al., 1998) . Constructs containing cDNA of the full-length Bcl-3 interactors were cloned by inserting the PCR-ampli®ed cDNA into the BamHI ± XhoI cleaved pPac vector (Hirano et al., 1998) . SL2 cells were seeded in 60 mm dishes at a density of 5610 5 cells/ ml 24 h before they were transfected by calcium phosphate precipitation as described previously (Hirano et al., 1998) .
Forty eight hours after transfection the cells were harvested, washed with phosphate-buered saline, lysed and analysed with the luciferase assay system.
